UCB Biopharma

• A study to learn more about the amount of bimekizumab in the breast milk of women with chronic inflammatory conditions who are breastfeeding Pending
  2024-518689-29-00 Phase I (Other) 2 countries BIMEKIZUMAB
• A study to learn if bimekizumab given in different ways is safe and moves similarly throughout the body over time in adults Recruiting
  2025-522782-30-00 Phase I (Other) 6 countries
• A study to learn how safe bimekizumab is and how well it works in adults with palmoplantar pustulosis Recruiting
  2024-520337-80-00 Phase III 8 countries BIMEKIZUMAB
• A study to learn if galvokimig is safe and works in adults with moderate to severe atopic dermatitis Recruiting
  2025-522578-35-00 Phase II 5 countries GALVOKIMIG
• A study to learn how the study drug bimekizumab works and how safe it is in treating moderate to severe hidradenitis suppurativa in children… Recruiting
  2023-505323-31-00 Phase III 2 countries BIMEKIZUMAB
• A study to learn how safe zilucoplan is in children with generalized myasthenia gravis who participated in a previous study about zilucoplan Recruiting
  2022-502073-42-00 Phase III 2 countries ZILUCOPLAN; ZILUCOPLAN SODIUM
• A study to learn how zilucoplan moves throughout the body over time and how safe it is in children with generalized myasthenia gravis Recruiting
  2022-502072-23-00 Phase II/III 2 countries ZILUCOPLAN; ZILUCOPLAN SODIUM
• A study to learn if bimekizumab is safe and how it moves throughout the body in children with certain types of juvenile idiopathic arthritis Recruiting
  2023-508845-41-00 Phase III 4 countries BIMEKIZUMAB
• A study to learn if dapirolizumab pegol works and is safe in people with moderately to severely active systemic lupus erythematosus (SLE) Recruiting
  2023-508191-11-00 Phase III 9 countries DAPIROLIZUMAB PEGOL
• An extension study to find out if multiple treatment cycles of rozanolixizumab are safe and work in children with myasthenia gravis Recruiting
  2022-502075-34-00 Phase III 2 countries ROZANOLIXIZUMAB
• A study to learn how bimekizumab works in children and teenagers with moderate to severe plaque psoriasis Recruiting
  2023-503859-10-00 Phase III 8 countries BIMEKIZUMAB; USTEKINUMAB
• A study to learn if rozanolixizumab is safe, how it moves through the body, and if it works in children with myasthenia gravis Recruiting
  2022-502074-16-00 Phase II/III 2 countries ROZANOLIXIZUMAB
• An extension study to learn if Staccato Alprazolam is safe when treating long seizures in children ≥12 years of age and adults Recruiting
  2023-508868-30-00 Phase III 7 countries ALPRAZOLAM
• An outpatient study to learn if Staccato Alprazolam is safe and effective when treating long seizures in children ≥12 years of age and adult… Recruiting
  2024-510950-29-00 Phase III 8 countries ALPRAZOLAM
• A study to learn how well bimekizumab works and how safe it is in adults with psoriatic arthritis Ended
  2024-511738-11-00 Phase III 6 countries BIMEKIZUMAB; RISANKIZUMAB
• A study to learn about the safety of long-term treatment with brivaracetam in children and young adults with childhood or juvenile absence e… Ended
  2023-508095-11-00 Phase III 4 countries BRIVARACETAM
• A study to learn how bimekizumab works in people with moderate to severe plaque psoriasis. Ended
  2023-506333-29-00 Phase III/IV 2 countries BIMEKIZUMAB
• A study to learn if Rozanolixizumab works and is safe over a long period in adults with relapsing myelin oligodendrocyte glycoprotein antibo… Ended
  2023-509237-39-00 Phase III 10 countries ROZANOLIXIZUMAB
• A study to learn if dapirolizumab pegol is safe and works long-term in people with systemic lupus erythematosus Ended
  2023-506368-14-00 Phase III 13 countries DAPIROLIZUMAB PEGOL
• An extension study to learn if Zilucoplan is safe and works over a long period in adult participants with generalized myasthenia gravis. Ended
  2024-512399-37-00 Phase III 4 countries ZILUCOPLAN
• An extension study to learn if bepranemab (UCB0107) is safe over a long period in adults with progressive supranuclear palsy Ended
  2024-510951-36-00 Phase I (Other) 3 countries BEPRANEMAB
• A study to learn how much minzasolmin gets into the body when taken in different ways and how safe it is in healthy adults Ended
  2024-511301-31-00 Phase I (Other) 1 country MINZASOLMIN
• A study to learn if a Zilucoplan auto-injector is safe and works in adults with myasthenia gravis Ended
  2023-508287-30-00 Phase III 1 country ZILUCOPLAN SODIUM
• A study to learn how zilucoplan moves throughout the body over time when given in 2 different ways in healthy adults Ended
  2023-508388-64-00 1 country

Showing 1–24 of 33 trials